Genetic polymorphisms influence variability in benzene metabolism in humans

Pharmacogenetics

Volumn 9, Issue 4, 1999, Pages 445-451

  Rossi, Anna M ^a   Guarnieri, C ^a   Rovesti, S ^b   Gobba, F ^b   Ghittori, S ^c   Vivoli, G ^b   Barale, R ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c IRCCS   (Italy)

Author keywords

Benzene derivatives; CYP2D6; CYP2E1; Genetic polymorphism; GSTM1; GSTP1; GSTT1; NQOR

Indexed keywords

ACETYLCYSTEINE DERIVATIVE; BENZENE DERIVATIVE; CREATININE; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; MUCONIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNSPECIFIC MONOOXYGENASE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BIOTRANSFORMATION; COFFEE; DRIVER; DRUG METABOLISM; EXHAUST GAS; GENE LOCUS; GENETIC POLYMORPHISM; HEALTH HAZARD; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC RATE; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; URINARY EXCRETION;

EID: 0032879511     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Agundez J, Ladero J, Diaz-Rubio M, Benitez J. Rsa I polymorphism at the cytocromt P4502E1 locus is not related to the risk of alcohol-related severe liver disease. Liver 1996; 16:380-83.
2. Bratton SB, Lau SS, Monks TJ. Identification of quinol thioethers in bone marrow of hydroquinone-phenol-treated rats and mice and their potential role in benzene-mediated hematotoxicity. Chem Res Toxicol 1997; 10:859-865.
3. Ghittori S, Fiorentino ML, Maestri L, Cordioli G, Imbriani M. Urinary excretion of unmetabolized benzene as an indicator of benzene exposure. J Toxicol Environ Health 1993; 38:233-243.
4. Gobba F, Rovesti S, Borella P, Vivoli R, Caselgrandi E, Vivoli G. Inter-individual variability of benzene metabolism to trans, transmuconic acid and its implications in the biological monitoring of occupational exposure. Sci Total Environ 1997; 199:41-48.
5. Gobba F, Ghittori S, Imbriani M, Maestri L, Capodaglio E, Cavalleri A. The urinary excretion of solvents and gases for the biological monitoring of occupational exposure: a review, Sci Total Environ 1997; 199:3-12.
6. Goldstein BD. Introduction: Occam's razor is dull. Environ Health Perspect 1989; 82:3-6.
7. Gough AC, Smith CAD, Howell SM, Wolf CR, Bryant SP, Spurr NK. Localization of the CYP2D gene locus to human chromosome 22q13.1 by polymerase chain reaction, in situ hybridization, and linkage analysis. Genomics 1993; 15:430-432.
8. Grove J, Brown ASJM, Daly AK, Bassendine MF, James OFW, Day CP. The Rsa I polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype. Pharmacogenetics 1998; 8:335-342.
9. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997; 18:641-644.
10. Hayashi SI, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450HE1 gene. J Biochem 1991; 110:559-565.
11. Johansson I, Ingelman-Sundberg M. Hydroxyl radical-mediated cytochrome P450-dependent metabolic activation of benzene in microsomes and reconstituded enzyme systems from rabbit liver. J Biol Chem 1983; 258:7311-7316.
12. Landi S, Norppa H, Frenzilli G, Cipollini G, Ponzanelli I, Barale R, Hirvonen A. Individual sensitivity to cytogenetic effects of 1,2,3,4-diepoxybutane in cultured human lymphocytes: influence of glutatione S-stransferase M1, P1, and T1 genotypes. Pharmacogenetics 1998; 8:461-471.
13. Maestri L, Ghittori S, Grignani E, Fiorentino ML, Imbrioni M. Measurement in humans of benzene metabolite urinary S-phenylmercapturic acid (S-PMA) with HPLC. Med Lav 1993; 84:55-65.
14. Matthias C, Bockmuhl U, Jahnke V, Harries LW, Wolf CR, Jones PW, et al. The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics 1998; 8:1-6.
15. Norppa, H, Hirvonen, A, Jarventaus, H, Uuskula, M, Tasa, G, Ojajarvi, A, Sorsa M. Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes. Carcinogenesis 1995; 16:1261-1264.
16. Parke DV. The cytochromes P450 and mechanisms of chemical carcinogenesis. Environ Health Perspect 1994; 102:852-853.
17. Parke DV. Personal reflections on 50 years of study of benzene toxicology. Environ Health Perspect Suppl 1996; 104:1123-1128.
18. Rauscher, D, Lehnert, G, Angerer J. Biomonitoring of occupational and environmental exposures to benzene by measuring trans, trans-muconic acid in urine. Clin Chem 1994; 40:1468-1470.
19. Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH. Identification of an NAD(P)H: quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics 1995; 5:199-206.
20. Rothman, N, Smith MT, Hayes RB, Traver RD, Hoener, B, Campleman S, et al. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1609 C (T mutation & rapid fractional excretion of chlorzoxazone. Cancer Res 1997; 57:2839-2842.
21. Saarikowski ST, Voho A, Reinikainen M, Anttila S, Karjalainen A, Malaveille C, et al. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 1998; 77:516-21.
22. Schultz WA, Krummeck A, Rosinger I, Eickelmann P, Neuhaus C, Ebert T, et al. Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics 1997; 7:235-239.
23. Smith CAD, Gough AC, Leigh PN, Summers BA, Harding AE, Maranganore DM, et al. Debrisoquine hydroxylase gene polimorphism and susceptibility to Parkinson's disease. Lancet 1992; 339; 1375-1377.
24. Snyder, R, Hedli CC. An overview of benzene metabolism. Environ Health Persp Suppl 1996; 104:1165-1171.
25. Subrahmanyam V, Kolachana P, Smith MT. Hydroxylation of phenol to hydroquinone catalysed by a human myeloperoxidase-superoxide complex: possible implications in benzene-induced myeloloxicity. Free Radic Res Commun 1991; 15:285-296.
26. Vivoli, G, Rovesti, S, Bergomi, M, Vivoli, R, Ferrari A. Monitoraggio dell'esposizione a benzene in ambiente urbano. In: Minoia C, Apostoli P, Bartolucci GB, eds. II benzene - tossicologia, ambienti di vita e di lavoro. Milano: Morgan Edizioni Tecniche: 1995. pp. 303-309.
27. Vivoli G, Rovesti S, Bergomo M, Vivoli R, Caselgrandi E. Interindividual variability in benzene metabolism for health risk assessment. 8th Annual Conference of the International Society for Environmental Epidemiology, 17-21 August 1996, Edmonton, Canada. Epidemiology 1996; 7:S87.
28. Wallace L. Major sources of exposure to benzene and other volatile organic chemicals. Risk Anal 1990; 10:59-64.
29. Weisel C, Yu R, Roy A, Georgopoulos P. Biomarkers of environmental benzene exposure. Environ Health Perspect Suppl 1996; 104:1141-1146.